ICH M10 is the first-ever global set of guidelines for [...]
By Tawny Britton|2023-10-12T15:16:46-04:00October 2nd, 2023|Comments Off on Bioanalytical Method Validation: Challenges and Opportunities of a Globally Harmonized System (ICH M10)
Japan represents an attractive and largely untapped market for each [...]
By Tawny Britton|2023-10-03T23:04:04-04:00September 22nd, 2022|Comments Off on The Japanese Market Presents Additional Opportunities for Drug Development and Commercialization
The Latest Insights into Clinical Studies in Japan The Pharma [...]
By Tawny Britton|2023-10-02T22:32:32-04:00January 12th, 2022|Comments Off on Clinical Studies In Japan Today: Another Look At The World’s Second-Largest Prescription Drug Market In A Post-Pandemic World
New Pharma Opportunities And Market Access Challenges In Japan Download [...]
By Kayo Komatsuzaki|2023-10-05T09:54:11-04:00September 28th, 2020|Comments Off on [Whitepaper] New Pharma Opportunities And Market Access Challenges In Japan
Development and Manufacturing: Insights into the Precision Medicine Model Download [...]
By Tawny Britton|2023-10-05T09:55:34-04:00July 28th, 2020|Comments Off on [Whitepaper] Drug Manufacturing And Development In The Age Of Precision Medicine
[CMIC Group Whitepaper] For decades, analytical testing has played a [...]
By Tawny Britton|2023-10-05T15:14:12-04:00July 21st, 2020|Comments Off on [White Paper] Tailoring Bioanalytical Testing In A New Era Of Drug Development